Genmab A/S carries a market capitalization of 15.00B, placing it among publicly traded companies globally.
| Market Cap | 15.00B |
| Enterprise Value | N/A |
Genmab A/S's stock has gained approximately 39.01396% over the past 52 weeks. The 50-day moving average sits at 224.43, while the 200-day moving average is 238.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | 39.01396% |
| 50-Day Moving Average | 224.43 |
| 200-Day Moving Average | 238.39 |
| Average Volume (20 Days) | N/A |